Global Somatropin Market Size & Share to 2027
Global Somatropin Market Size, Trends & Growth Opportunity, By Dosage Form (Powder, and Solvent) By Application (Growth Hormone Deficiency (GHD), Turner Syndrome, Chronic Rental Insufficiency, Prader Willi Syndrome, SHOX Deficiency, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region and Forecast till 2027
Global Somatropin Market
Somatropinn is a human growth hormone indicated for the treatment of growth hormone deficiency in adults and children. Also, it is used for treatment of Prader-Willi syndrome, Chronic Renal Insufficiency, Turner syndrome Turner syndrome, and others. Somatropin stimulates tissue growth, and protein, lipid, carbohydrates and mineral metabolism in the body.
Market Drivers
Rise in approvals of somatropin products by regulatory authorities such as USFDA (Food and Drug Administration) is the key driving factor which is expected to boost the global somatropin market growth. For instance, in July 2018, U.S. Food and Drug Administration had approved ZOMACTON, a Somatropin injection of Ferring Pharmaceuticals Inc, for additional pediatric indications such as Idiopathic short stature (ISS), Growth failure in short stature homeobox-containing gene (SHOX) deficiency, Short stature born small for gestational age (SGA) with no catch-up growth by 2 to 4 years, and Short stature due to Turner syndrome. Furthermore, increase in prevalence of growth hormobe deficiency in children will positively contribute the market growth over the forecast period. As per article published in the Springer Nature Journal in Feb 2017, the prevalence of GHD (Growth Hormone Deficiency) in children is within range 1.8 -2.9 per 10,000 children in Europe and the U.S.
Market Restraints
However, key manufacturers are focused on developing advanced alternative treatments for growth hormone deficiency is the major challenging factor which is expected to hinder the global somatropin market growth. For instance, in October 2019, OPKO Health and Pfizer had announced the results of Phase III clinical trials, which was initiated to evaluate the efficacy and safety of somatrogen, which is long acting human growth hormone molecule administrated once in a week for growth hormone deficiency.
Market segmentation
Global Somatropin Market is segmented into dosage form such as Powder, and Solvent, by application such as Growth Hormone Deficiency (GHD), Turner Syndrome, Chronic Rental Insufficiency, Prader Willi Syndrome, SHOX Deficiency, and Others. Further, market is segmented into distribution channel such as Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.
Also, Global Somatropin Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Market Key Players
Various key players are discussed in this report such as Novo Nordisk A/S, Eli Lilly and Company, Pfizer, Inc., GeneScience Pharmaceuticals, Ipsen Inc.,Sandoz International, LG Life Sciences, Merck, Hoffmann-La Roche, and Teva Pharmaceuticals.
Market Taxonomy
By Dosage Form
- Powder
- Solvent
- Growth Hormone Deficiency (GHD)
- Turner Syndrome
- Chronic Rental Insufficiency
- Prader Willi Syndrome
- SHOX Deficiency
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
- What are the Key Opportunities in Global Somatropin Market?
- What will be the growth rate from 2019 to 2027?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the competitive Landscape in the Industry?
- What is the role of key players in the value chain?
- What are the strategies adopted by key players?
- 1 Introduction
- 1.1 Objective of the Study
- 1.2 Market Definition
- 1.3 Market Scope
- 2 Research Methodology
- 2.1 Data Mining
- 2.2 Validation
- 2.3 Primary Interviews
- 2.4 List of Data Sources
- 3 Executive Summary
- 4 Global Somatropin Market Outlook
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
- 5 Global Somatropin Market, By Dosage Form
- 5.1 Y-o-Y Growth Comparison, By Dosage Form
- 5.2 Global Somatropin Market Share Analysis, By Dosage Form
- 5.3 Global Somatropin Market Size and Forecast, By Dosage Form
- 5.3.1 Powder
- 5.3.2 Solvent
- 6 Global Somatropin Market, By Application
- 6.1 Y-o-Y Growth Comparison, By Application
- 6.2 Global Somatropin Market Share Analysis, By Application
- 6.3 Global Somatropin Market Size and Forecast, By Application
- 6.3.1 Growth Hormone Deficiency (GHD)
- 6.3.2 Turner Syndrome
- 6.3.3 Prader Willi Syndrome
- 6.3.4 SHOX Deficiency
- 6.3.5 Others
- 7 Global Somatropin Market, By Distribution Channel
- 7.1 Y-o-Y Growth Comparison, By Distribution Channel
- 7.2 Global Somatropin Market Share Analysis, By Distribution Channel
- 7.3 Global Somatropin Market Size and Forecast, By Distribution Channel
- 7.3.1 Hospital Pharmacies
- 7.3.2 Retail Pharmacies
- 7.3.3 Online Pharmacies
- 8 Global Somatropin Market, By Region
- 8.1 Global Somatropin Market Share Analysis, By Region
- 8.2 Global Somatropin Market Share Analysis, By Region
- 8.3 Global Somatropin Market Size and Forecast, By Region
- 9 North America Somatropin Market Analysis and Forecast (2020-2027)
- 9.1 Introduction
- 9.2 North America Somatropin Market Share Analysis, By Dosage Form
- 9.3 North America Somatropin Market Size and Forecast, By Application
- 9.4 North America Somatropin Market Size and Forecast, By Distribution Channel
- 9.5 North America Somatropin Market Size and Forecast, By Country
- 9.5.1 U.S.
- 9.5.2 Canada
- 9.5.3 Mexico
- 10 EuropeSomatropin Market Analysis and Forecast (2020-2027)
- 10.1 Introduction
- 10.2 Europe Somatropin Market Share Analysis, By Dosage Form
- 10.3 Europe Somatropin Market Size and Forecast, By Application
- 10.4 Europe Somatropin Market Size and Forecast, By Distribution Channel
- 10.5 Europe Somatropin Market Size and Forecast, By Country
- 10.5.1 Germany
- 10.5.2 France
- 10.5.3 UK
- 10.5.4 Rest of Europe
- 11 Asia Pacific Somatropin Market Analysis and Forecast (2020-2027)
- 11.1 Introduction
- 11.2 Asia Pacific Somatropin Market Share Analysis, By Dosage Form
- 11.3 Asia Pacific Somatropin Market Size and Forecast, By Application
- 11.4 Asia Pacific Somatropin Market Size and Forecast, By Distribution Channel
- 11.5 Asia Pacific Somatropin Market Size and Forecast, By Country
- 11.5.1 China
- 11.5.2 Japan
- 11.5.3 India
- 11.5.4 Rest of Asia Pacific
- 12 Latin America Somatropin Market Analysis and Forecast (2020-2027)
- 12.1 Introduction
- 12.2 Latin America Somatropin Market Share Analysis, By Dosage Form
- 12.3 Latin America Somatropin Market Size and Forecast, By Application
- 12.4 Latin America Somatropin Market Size and Forecast, By Distribution Channel
- 12.5 Latin America Somatropin Market Size and Forecast, Country
- 13 Middle East Somatropin Market Analysis and Forecast (2020-2027)
- 13.1 Introduction
- 13.2 Middle East Somatropin Market Share Analysis, By Dosage Form
- 13.3 Middle East Somatropin Market Size and Forecast, By Application
- 13.4 Middle East Somatropin Market Size and Forecast, By Distribution Channel
- 13.5 Middle East Somatropin Market Size and Forecast, By Country
- 14 Competitive Analysis
- 14.1 Competition Dashboard
- 14.2 Market share Analysis of Top Vendors
- 14.3 Key Development Strategies
- 15 Company Profiles
- 15.1 Novo Nordisk A/S
- 15.1.1 Overview
- 15.1.2 Offerings
- 15.1.3 Key Financials
- 15.1.4 Business Segment & Geographic Overview
- 15.1.5 Key Market Developments
- 15.1.6 Key Strategies
- 15.2. Eli Lilly and Company
- 15.2.1 Overview
- 15.2.2 Offerings
- 15.2.3 Key Financials
- 15.2.4 Business Segment & Geographic Overview
- 15.2.5 Key Market Developments
- 15.2.6 Key Strategies
- 15.3. Pfizer, Inc
- 15.3.1 Overview
- 15.3.2 Offerings
- 15.3.3 Key Financials
- 15.3.4 Business Segment & Geographic Overview
- 15.3.5 Key Market Developments
- 15.3.6 Key Strategies
- 15.4 GeneScience Pharmaceuticals
- 15.4.1 Overview
- 15.4.2 Offerings
- 15.4.3 Key Financials
- 15.4.4 Business Segment & Geographic Overview
- 15.4.5 Key Market Developments
- 15.4.6 Key Strategies
- 15.5 Ipsen Inc
- 15.5.1 Overview
- 15.5.2 Offerings
- 15.5.3 Key Financials
- 15.5.4 Business Segment & Geographic Overview
- 15.5.5 Key Market Developments
- 15.5.6 Key Strategies
- 15.6 Sandoz International
- 15.6.1 Overview
- 15.6.2 Offerings
- 15.6.3 Key Financials
- 15.6.4 Business Segment & Geographic Overview
- 15.6.5 Key Market Developments
- 15.6.6 Key Strategies
- 15.7 LG Life Sciences
- 15.7.1 Overview
- 15.7.2 Offerings
- 15.7.3 Key Financials
- 15.7.4 Business Segment & Geographic Overview
- 15.7.5 Key Market Developments
- 15.7.6 Key Strategies
- 15.8 Merck
- 15.8.1 Overview
- 15.8.2 Offerings
- 15.8.3 Key Financials
- 15.8.4 Business Segment & Geographic Overview
- 15.8.5 Key Market Developments
- 15.8.6 Key Strategies
- 15.9 Hoffmann-La Roche
- 15.9.1 Overview
- 15.9.2 Offerings
- 15.9.3 Key Financials
- 15.9.4 Business Segment & Geographic Overview
- 15.9.5 Key Market Developments
- 15.9.6 Key Strategies
- 15.10 Teva Pharmaceuticals
- 15.10.1 Overview
- 15.10.2 Offerings
- 15.10.3 Key Financials
- 15.10.4 Business Segment & Geographic Overview
- 15.10.5 Key Market Developments
- 15.10.6 Key Strategies
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook